Phosphatase and TENsin homolog (PTEN), Erythroblast transformation-specific–related gene (ERG), Serine protease inhibitor Kazal-type 1 (SPINK1), and Trefoil Factor 3 (TFF3) have been identified as important biomarkers for prostate cancer. This evidence concerns the gene ERG and prostate cancer.